Cured Overview
- Founded
- 2018
- Status
- Private
- Employees
- 51
- Latest Deal Type
- Series A
- Latest Deal Amount
- $10M
- Investors
- 7
Cured General Information
Description
Operator of a healthcare digital marketing and customer relationship management platform designed to address enterprise-scale challenges in healthcare and life sciences organizations. The company's cloud-based platform provides design and product development services, leverages modern business and network development tools, integrates contact center with electronic medical records and provide a centralized tool to quickly access all the resources, enabling clients to increase brand awareness, improve patient satisfaction, increase patients quality care and create engaging digital experiences.
Contact Information
Website
www.cured.health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Services
Primary Office
- 5328 North Delaware Street
- Indianapolis, IN 46220
- United States
Cured Timeline
Cured Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 15-Sep-2021 | $10M | 000.00 | 0000 | Completed | Generating Revenue |
| 1. Seed Round | 25-Sep-2019 | 00.00 | 00.00 | 00.00 | Completed | Generating Revenue |
Cured Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
| Seed | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Cured Patents
Cured Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9765151-B2 | Method for producing monoclonal iga antibody | Expired - Fee Related | 11-Mar-2013 | 000000000 | 0 |
| US-20160039944-A1 | Method for producing monoclonal iga antibody | Granted | 11-Mar-2013 | 000000000 |
Cured Executive Team (3)
Cured Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrew Sawyer | Cured | Co-Founder, Chief Executive Officer, Board Member and President | 000 0000 |
| Ashmer Aslam | Cured | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
| Partha Mishra | DNA Capital (Investor) | Board Member | 000 0000 |
Cured Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCured Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CU Healthcare Innovation Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| DNA Capital (Investor) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| University of Colorado Health | University | Minority | 000 0000 | 000000 0 | |
| Headwater Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| High Alpha | Venture Capital | Minority | 000 0000 | 000000 0 |